Stockscreener 앱 받기
152.72
1.52%
-2.35
시간 외 거래:
152.72
전일 마감가:
$155.07
열려 있는:
$154.05
하루 거래량:
672.33K
Relative Volume:
0.69
시가총액:
$8.97B
수익:
$551.35M
순이익/손실:
$-189.33M
주가수익비율:
-46.40
EPS:
-3.2916
순현금흐름:
$-35.09M
1주 성능:
+2.95%
1개월 성능:
+24.68%
6개월 성능:
+35.25%
1년 성능:
+43.33%
1일 변동 폭
$143.11
$156.60
1주일 범위
$143.11
$156.60
52주 변동 폭
$73.16
$156.60
Glaukos Corp Stock (GKOS) Company Profile
명칭
Glaukos Corp
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corp
|
152.72 | 9.11B | 551.35M | -189.33M | -35.09M | -3.2916 |
ABT
Abbott Laboratories
|
93.93 | 164.43B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 125.40B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 105.46B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.87B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 52.59B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glaukos Corp Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | 개시 | Goldman | Buy |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corp 주식(GKOS)의 최신 뉴스
Price to sales forward of Glaukos Corp – XETR:6GJ - TradingView
Form 144 GLAUKOS Corp For: 9 July By Investing.com - Investing.com Australia
Form 144 GLAUKOS Corp For: 9 July - Investing.com UK
Midday Stock Roundup: Alignment Healthcare Up 7.8% Ahead of Q2 Results - Orange County Business Journal
Glaukos (GKOS) Form 144 shows 10,000-share sale, option exercise - Stock Titan
Glaukos Corp CFO Alex Thurman sells $1.5m in shares - Investing.com
Form 4 Glaukos Corp For: 8 July By Investing.com - Investing.com Nigeria
Glaukos chief development officer Navratil sells $99,566 stock By Investing.com - Investing.com Nigeria
Glaukos (GKOS) CFO executes pre-planned share sale and option exercise - Stock Titan
Glaukos chief development officer Navratil sells $99,566 stock - Investing.com
Glaukos (GKOS) chief development officer sells 716 shares under 10b5-1 plan - Stock Titan
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
GKOS Maintained by Citigroup -- Price Target Raised to $175 - GuruFocus
GKOS Stock Up More Than 45% Since May-End: What's Driving the Rally? - Yahoo Finance
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29 - Business Wire
Glaukos Corp stock and its role in eye disease treatment - ad-hoc-news.de
Form 144 GLAUKOS Corp For: 6 July By Investing.com - Investing.com Nigeria
Glaukos (NYSE: GKOS) files Form 144 to sell 10,000 shares - Stock Titan
Glaukos stock rating reiterated at Outperform by William Blair - Investing.com
Glaukos Rises as Reimbursement Milestone and Recent Pipeline Updates Support Sentiment - Quiver Quantitative
Glaukos stock hits 52-week high at 148.12 USD By Investing.com - Investing.com Nigeria
Glaukos stock hits 52-week high at 148.12 USD - Investing.com
Form 144 GLAUKOS Corp For: 1 July - Investing.com UK
Form 144 GLAUKOS Corp For: 1 July By Investing.com - Investing.com Canada
GKOS (GKOS) insider sells 3,630 shares total across April and June 2026 - Stock Titan
GKOS Reiterated by Piper Sandler -- Price Target Maintained at $165 - GuruFocus
Piper Sandler reiterates Glaukos stock rating on iDose headwinds By Investing.com - Investing.com Nigeria
Piper Sandler reiterates Glaukos stock rating on iDose headwinds - Investing.com
Form 4 Glaukos Corp For: 29 June By Investing.com - Investing.com South Africa
Glaukos (NYSE: GKOS) CEO updates trust holdings, uses shares for tax withholding - Stock Titan
Form 4 Glaukos Corp For: 29 June - Investing.com UK
Glaukos (NYSE: GKOS) president has 1,056 shares withheld for taxes - Stock Titan
Glaukos (GKOS) CDO reports 483-share tax withholding, holds 88,350 shares - Stock Titan
Enterprise value to EBIT forward of Glaukos Corp – XETR:6GJ - TradingView
Price to book forward of Glaukos Corp – XETR:6GJ - TradingView
Enterprise value to EBITDA forward of Glaukos Corp – XETR:6GJ - TradingView
Goldman Sachs Small Cap Equity Insights Fund's Glaukos Corp(GKOS) Holding History - GuruFocus
Glaukos Corp Actuals & Estimates (NYSE:GKOS) - TradingView
Glaukos Moves Into Demodex Blepharitis Space - Orange County Business Journal
Glaukos completes enrollment in phase 2 blepharitis study - Investing.com
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis - BioSpace
Glaukos completes enrollment in phase 2 blepharitis study By Investing.com - Investing.com Australia
Glaukos (GKOS) Completes Patient Enrollment in GLK-321 Study - GuruFocus
Glaukos fills 275-patient trial of eyelid-disease drug candidate - Stock Titan
Glaukos Corp (GKOS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 4 Glaukos Corp For: 23 June By Investing.com - Investing.com Nigeria
Form 4 Glaukos Corp For: 23 June - Investing.com UK
Glaukos (NYSE: GKOS) director updates stock option grant to $106.52 strike - Stock Titan
Glaukos (NYSE: GKOS) director Leana Wen awarded 2,987 stock options at $106.52 - Stock Titan
GLAUKOS (GKOS) director Stapley gets 2,987 options at corrected $106.52 strike - Stock Titan
Glaukos Corp (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
자본화:
|
볼륨(24시간):